Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 756 entries
Sorted by: Best Match Show Resources per page
Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells.

Scientific reports

Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, Okazaki Y, Brosens JJ, Ishihara O.
PMID: 28443632
Sci Rep. 2017 Apr 26;7:46591. doi: 10.1038/srep46591.

No abstract available.

Cite
Tochigi H, Kajihara T, Mizuno Y, et al. Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017;7:46591doi: 10.1038/srep46591.
Tochigi, H., Kajihara, T., Mizuno, Y., Mizuno, Y., Tamaru, S., Kamei, Y., Okazaki, Y., Brosens, J. J., & Ishihara, O. (2017). Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Scientific reports, 746591. https://doi.org/10.1038/srep46591
Tochigi, Hideno, et al. "Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells." Scientific reports vol. 7 (2017): 46591. doi: https://doi.org/10.1038/srep46591
Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, Okazaki Y, Brosens JJ, Ishihara O. Erratum: Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017 Apr 26;7:46591. doi: 10.1038/srep46591. PMID: 28443632; PMCID: PMC5405451.
Copy Download .nbib Format: NLM
Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Tanaka H, Yamaguchi T, Hachiya K, Hayashi M, Ogawa S, Nishibori H, Kamei S, Ishihara S, Matsuo M, Kellam SG.
PMID: 28951699
Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):477-481. doi: 10.1016/j.rpor.2017.08.009. Epub 2017 Sep 19.

AIM: To assess the changes in prostate size in patients with prostate cancer undergoing intensity-modulated radiation therapy (IMRT).BACKGROUND: The effect of size change produced by IMRT is not well known.MATERIALS AND METHODS: We enrolled 72 patients who received IMRT...

Cite
Tanaka H, Yamaguchi T, Hachiya K, et al. Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Rep Pract Oncol Radiother. 2017;22(6):477-481doi: 10.1016/j.rpor.2017.08.009.
Tanaka, H., Yamaguchi, T., Hachiya, K., Hayashi, M., Ogawa, S., Nishibori, H., Kamei, S., Ishihara, S., Matsuo, M., & Kellam, S. G. (2017). Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 22(6), 477-481. https://doi.org/10.1016/j.rpor.2017.08.009
Tanaka, Hidekazu, et al. "Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone." Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology vol. 22,6 (2017): 477-481. doi: https://doi.org/10.1016/j.rpor.2017.08.009
Tanaka H, Yamaguchi T, Hachiya K, Hayashi M, Ogawa S, Nishibori H, Kamei S, Ishihara S, Matsuo M, Kellam SG. Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone. Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):477-481. doi: 10.1016/j.rpor.2017.08.009. Epub 2017 Sep 19. PMID: 28951699; PMCID: PMC5607145.
Copy Download .nbib Format: NLM
Temporal lobe epilepsy associated with GAD autoimmunity.

Acta diabetologica

Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H.
PMID: 27638303
Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08.

No abstract available.

Cite
Obata A, Kutoku Y, Sunada Y, et al. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2016;54(3):321-323doi: 10.1007/s00592-016-0910-9.
Obata, A., Kutoku, Y., Sunada, Y., Okauchi, S., Kimura, T., Hirukawa, H., Tanabe, A., Kinoshita, T., Kohara, K., Tatsumi, F., Shimoda, M., Kamei, S., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2017). Temporal lobe epilepsy associated with GAD autoimmunity. Acta diabetologica, 54(3), 321-323. https://doi.org/10.1007/s00592-016-0910-9
Obata, Atsushi, et al. "Temporal lobe epilepsy associated with GAD autoimmunity." Acta diabetologica vol. 54,3 (2017): 321-323. doi: https://doi.org/10.1007/s00592-016-0910-9
Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H. Temporal lobe epilepsy associated with GAD autoimmunity. Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 08. PMID: 27638303; PMCID: PMC5329084.
Copy Download .nbib Format: NLM
A case of vasa previa diagnosed prenatally, and review of the literature.

Journal of medical ultrasonics (2001)

Komatsu A, Kozuma S, Yoshida S, Hyodo H, Yamashita T, Kamei Y, Fujii T, Taketani Y.
PMID: 27278338
J Med Ultrason (2001). 2011 Jan;38(1):41-5. doi: 10.1007/s10396-010-0287-2. Epub 2010 Oct 30.

The perinatal mortality rate of vasa previa is high if it is not prenatally diagnosed. In this report, a case of vasa previa diagnosed prenatally is presented. Antepartum hemorrhage at 24 weeks of gestation prompted a close investigation of...

Cite
Komatsu A, Kozuma S, Yoshida S, et al. A case of vasa previa diagnosed prenatally, and review of the literature. J Med Ultrason (2001). 2010;38(1):41-5doi: 10.1007/s10396-010-0287-2.
Komatsu, A., Kozuma, S., Yoshida, S., Hyodo, H., Yamashita, T., Kamei, Y., Fujii, T., & Taketani, Y. (2011). A case of vasa previa diagnosed prenatally, and review of the literature. Journal of medical ultrasonics (2001), 38(1), 41-5. https://doi.org/10.1007/s10396-010-0287-2
Komatsu, Atsushi, et al. "A case of vasa previa diagnosed prenatally, and review of the literature." Journal of medical ultrasonics (2001) vol. 38,1 (2011): 41-5. doi: https://doi.org/10.1007/s10396-010-0287-2
Komatsu A, Kozuma S, Yoshida S, Hyodo H, Yamashita T, Kamei Y, Fujii T, Taketani Y. A case of vasa previa diagnosed prenatally, and review of the literature. J Med Ultrason (2001). 2011 Jan;38(1):41-5. doi: 10.1007/s10396-010-0287-2. Epub 2010 Oct 30. PMID: 27278338.
Copy Download .nbib Format: NLM
Tissue elastography imaging of the uterine cervix during pregnancy.

Journal of medical ultrasonics (2001)

Yamaguchi S, Kamei Y, Kozuma S, Taketani Y.
PMID: 27278485
J Med Ultrason (2001). 2007 Dec;34(4):209-10. doi: 10.1007/s10396-007-0150-2. Epub 2007 Dec 14.

No abstract available.

Cite
Yamaguchi S, Kamei Y, Kozuma S, et al. Tissue elastography imaging of the uterine cervix during pregnancy. J Med Ultrason (2001). 2007;34(4):209-10doi: 10.1007/s10396-007-0150-2.
Yamaguchi, S., Kamei, Y., Kozuma, S., & Taketani, Y. (2007). Tissue elastography imaging of the uterine cervix during pregnancy. Journal of medical ultrasonics (2001), 34(4), 209-10. https://doi.org/10.1007/s10396-007-0150-2
Yamaguchi, Syun-Ichi, et al. "Tissue elastography imaging of the uterine cervix during pregnancy." Journal of medical ultrasonics (2001) vol. 34,4 (2007): 209-10. doi: https://doi.org/10.1007/s10396-007-0150-2
Yamaguchi S, Kamei Y, Kozuma S, Taketani Y. Tissue elastography imaging of the uterine cervix during pregnancy. J Med Ultrason (2001). 2007 Dec;34(4):209-10. doi: 10.1007/s10396-007-0150-2. Epub 2007 Dec 14. PMID: 27278485.
Copy Download .nbib Format: NLM
Short- and long-term outcomes of third liver transplantation at single centre.

Hepatology international

Kamei H, Al-Basheer M, Shum J, Bloch M, Alejandro RH, McAlister V, Wall W, Quan D.
PMID: 26201807
Hepatol Int. 2013 Jun;7(2):728-33. doi: 10.1007/s12072-012-9364-5. Epub 2012 Mar 14.

PURPOSE: Although three or more liver transplantation (LT)s in the same patient arouse not only medical but also ethical issues in the context of organ shortage, it is a fact that additional liver retransplantation (reLT) is the only lifesaving...

Cite
Kamei H, Al-Basheer M, Shum J, et al. Short- and long-term outcomes of third liver transplantation at single centre. Hepatol Int. 2012;7(2):728-33doi: 10.1007/s12072-012-9364-5.
Kamei, H., Al-Basheer, M., Shum, J., Bloch, M., Alejandro, R. H., McAlister, V., Wall, W., & Quan, D. (2013). Short- and long-term outcomes of third liver transplantation at single centre. Hepatology international, 7(2), 728-33. https://doi.org/10.1007/s12072-012-9364-5
Kamei, Hideya, et al. "Short- and long-term outcomes of third liver transplantation at single centre." Hepatology international vol. 7,2 (2013): 728-33. doi: https://doi.org/10.1007/s12072-012-9364-5
Kamei H, Al-Basheer M, Shum J, Bloch M, Alejandro RH, McAlister V, Wall W, Quan D. Short- and long-term outcomes of third liver transplantation at single centre. Hepatol Int. 2013 Jun;7(2):728-33. doi: 10.1007/s12072-012-9364-5. Epub 2012 Mar 14. PMID: 26201807.
Copy Download .nbib Format: NLM
Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs.

Hepatology international

Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N.
PMID: 26201930
Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31.

PURPOSE: Despite improvements in immunosuppressive therapy, acute cellular rejection (ACR) remains an important cause of graft loss in patients undergoing liver transplantation. Recently, associations between cytokine gene polymorphisms in recipients and the occurrence of ACR have been reported. However,...

Cite
Kamei H, Masuda S, Nakamura T, et al. Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatol Int. 2013;7(3):916-22doi: 10.1007/s12072-013-9443-2.
Kamei, H., Masuda, S., Nakamura, T., Ishigami, M., Fujimoto, Y., Ogura, Y., Oike, F., Takada, Y., & Hamajima, N. (2013). Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatology international, 7(3), 916-22. https://doi.org/10.1007/s12072-013-9443-2
Kamei, Hideya, et al. "Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs." Hepatology international vol. 7,3 (2013): 916-22. doi: https://doi.org/10.1007/s12072-013-9443-2
Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N. Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs. Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31. PMID: 26201930.
Copy Download .nbib Format: NLM
Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus.

International journal of surgery case reports

Ishida H, Nakano T, Fujishima F, Kamei T, Taniyama Y, Sakurai T, Sato C, Fukutomi T, Kamiya K, Ozawa Y, Sasano H, Ohuchi N.
PMID: 26629851
Int J Surg Case Rep. 2015;17:151-4. doi: 10.1016/j.ijscr.2015.11.013. Epub 2015 Nov 26.

INTRODUCTION: Basaloid squamous cell carcinoma of the oesophagus (BSCCE) is a relatively rare variant of oesophageal malignancy. There are no established treatment strategies for pulmonary metastases of BSCCE.PRESENTATION OF CASE: A 72-year-old man underwent oesophagectomy and subsequently received a...

Cite
Ishida H, Nakano T, Fujishima F, et al. Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus. Int J Surg Case Rep. 2015;17:151-4doi: 10.1016/j.ijscr.2015.11.013.
Ishida, H., Nakano, T., Fujishima, F., Kamei, T., Taniyama, Y., Sakurai, T., Sato, C., Fukutomi, T., Kamiya, K., Ozawa, Y., Sasano, H., & Ohuchi, N. (2015). Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus. International journal of surgery case reports, 17151-4. https://doi.org/10.1016/j.ijscr.2015.11.013
Ishida, Hirotaka, et al. "Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus." International journal of surgery case reports vol. 17 (2015): 151-4. doi: https://doi.org/10.1016/j.ijscr.2015.11.013
Ishida H, Nakano T, Fujishima F, Kamei T, Taniyama Y, Sakurai T, Sato C, Fukutomi T, Kamiya K, Ozawa Y, Sasano H, Ohuchi N. Surgical resection and chemoradiotherapy for metachronous pulmonary metastasis of basaloid squamous cell carcinoma of the oesophagus. Int J Surg Case Rep. 2015;17:151-4. doi: 10.1016/j.ijscr.2015.11.013. Epub 2015 Nov 26. PMID: 26629851; PMCID: PMC4701867.
Copy Download .nbib Format: NLM
ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis.

Cell reports

Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S.
PMID: 25683718
Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12.

Ataxia-telangiectasia (A-T) patients occasionally develop diabetes mellitus. However, only limited attempts have been made to gain insight into the molecular mechanism of diabetes mellitus development in A-T patients. We found that Atm

Cite
Takagi M, Uno H, Nishi R, et al. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015;10(6):957-967doi: 10.1016/j.celrep.2015.01.027.
Takagi, M., Uno, H., Nishi, R., Sugimoto, M., Hasegawa, S., Piao, J., Ihara, N., Kanai, S., Kakei, S., Tamura, Y., Suganami, T., Kamei, Y., Shimizu, T., Yasuda, A., Ogawa, Y., & Mizutani, S. (2015). ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell reports, 10(6), 957-967. https://doi.org/10.1016/j.celrep.2015.01.027
Takagi, Masatoshi, et al. "ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis." Cell reports vol. 10,6 (2015): 957-967. doi: https://doi.org/10.1016/j.celrep.2015.01.027
Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12. PMID: 25683718.
Copy Download .nbib Format: NLM
Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males.

Nigerian medical journal : journal of the Nigeria Medical Association

Ghasemzadeh A, Karkon-Shayan F, Yousefzadeh S, Naghavi-Behzad M, Hamdi K.
PMID: 27942099
Niger Med J. 2016 Nov-Dec;57(6):324-328. doi: 10.4103/0300-1652.193857.

BACKGROUND: The quality of semen is one of the major parameters in male infertility. Pentoxifylline, a methylxanthine derivative, is an agent primarily used in the treatment of intermittent claudication and other vascular disorders. Studies have shown that pentoxifylline enhances...

Cite
Ghasemzadeh A, Karkon-Shayan F, Yousefzadeh S, et al. Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males. Niger Med J. 2016;57(6):324-328doi: 10.4103/0300-1652.193857.
Ghasemzadeh, A., Karkon-Shayan, F., Yousefzadeh, S., Naghavi-Behzad, M., & Hamdi, K. (2016). Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males. Nigerian medical journal : journal of the Nigeria Medical Association, 57(6), 324-328. https://doi.org/10.4103/0300-1652.193857
Ghasemzadeh, Aliye, et al. "Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males." Nigerian medical journal : journal of the Nigeria Medical Association vol. 57,6 (2016): 324-328. doi: https://doi.org/10.4103/0300-1652.193857
Ghasemzadeh A, Karkon-Shayan F, Yousefzadeh S, Naghavi-Behzad M, Hamdi K. Study of pentoxifylline effects on motility and viability of spermatozoa from infertile asthenozoospermic males. Niger Med J. 2016 Nov-Dec;57(6):324-328. doi: 10.4103/0300-1652.193857. PMID: 27942099; PMCID: PMC5126744.
Copy Download .nbib Format: NLM
The Use of SCAN to Identify Children at Risk for CAPD: Response to Keith (1998).

Language, speech, and hearing services in schools

Emerson MF, Crandall KK, Seikel JA, Chermak GD.
PMID: 27764427
Lang Speech Hear Serv Sch. 1998 Apr 01;29(2):118-119. doi: 10.1044/0161-1461.2902.118.

No abstract available.

Cite
Emerson MF, Crandall KK, Seikel JA, et al. The Use of SCAN to Identify Children at Risk for CAPD: Response to Keith (1998). Lang Speech Hear Serv Sch. 1998;29(2):118-119doi: 10.1044/0161-1461.2902.118.
Emerson, M. F., Crandall, K. K., Seikel, J. A., & Chermak, G. D. (1998). The Use of SCAN to Identify Children at Risk for CAPD: Response to Keith (1998). Language, speech, and hearing services in schools, 29(2), 118-119. https://doi.org/10.1044/0161-1461.2902.118
Emerson, Maria F, et al. "The Use of SCAN to Identify Children at Risk for CAPD: Response to Keith (1998)." Language, speech, and hearing services in schools vol. 29,2 (1998): 118-119. doi: https://doi.org/10.1044/0161-1461.2902.118
Emerson MF, Crandall KK, Seikel JA, Chermak GD. The Use of SCAN to Identify Children at Risk for CAPD: Response to Keith (1998). Lang Speech Hear Serv Sch. 1998 Apr 01;29(2):118-119. doi: 10.1044/0161-1461.2902.118. PMID: 27764427.
Copy Download .nbib Format: NLM
One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK.

Clinical ophthalmology (Auckland, N.Z.)

Lip PL, Malick H, Damer K, Elsherbiny S, Darrad KM, Mushtaq B, Mitra A, Stavrou P, Yang Y.
PMID: 26445525
Clin Ophthalmol. 2015 Sep 25;9:1779-84. doi: 10.2147/OPTH.S89147. eCollection 2015.

BACKGROUND: The purpose of this study was to investigate the 12-month outcome of macular edema secondary to both chronic and new central and branch retinal vein occlusions treated with intravitreal bevacizumab in the real-life clinical setting in the UK.METHODS:...

Cite
Lip PL, Malick H, Damer K, et al. One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK. Clin Ophthalmol. 2015;9:1779-84doi: 10.2147/OPTH.S89147.
Lip, P. L., Malick, H., Damer, K., Elsherbiny, S., Darrad, K. M., Mushtaq, B., Mitra, A., Stavrou, P., & Yang, Y. (2015). One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK. Clinical ophthalmology (Auckland, N.Z.), 91779-84. https://doi.org/10.2147/OPTH.S89147
Lip, Peck Lin, et al. "One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK." Clinical ophthalmology (Auckland, N.Z.) vol. 9 (2015): 1779-84. doi: https://doi.org/10.2147/OPTH.S89147
Lip PL, Malick H, Damer K, Elsherbiny S, Darrad KM, Mushtaq B, Mitra A, Stavrou P, Yang Y. One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK. Clin Ophthalmol. 2015 Sep 25;9:1779-84. doi: 10.2147/OPTH.S89147. eCollection 2015. PMID: 26445525; PMCID: PMC4590638.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 756 entries